Related Experiment Video
Updated: Aug 30, 2026

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α
Published on: November 2, 2018
Upstream signal transduction of NF-kappaB activation
Fei Chen1, Laurence M Demers, Xianglin Shi
1The Health Effects Laboratory Division, National Institute for Occupational Safety and Health, 1095 Willowdale Road, Morgantown, WV 26505, USA. lfd3@cdc.gov
Abstract:
NF-kappaB is a transcription factor governing the expression of genes involved in the immune response, embryo or cell lineage development, cell apoptosis, cell cycle progression, inflammation, and oncogenesis. During the past few years, considerable attention has been paid to the upstream signaling pathways that lead to the activation of NF-kappaB. Many of these signaling molecules can serve as potential pharmaceutical targets for the specific inhibition of NF-kappaB activation leading to interruption of disease processes. How these molecules interact with each other is however, still a debatable issue. Since many of the signal molecules in this pathway relay more than one of the upstream signals to downstream targets, it has been suggested that the transmission of signals involves a network, rather than a linear sequence in the activation of NF-kappaB. Thus, the detailed elucidation of the upstream signaling molecules involved with NF-kappaB activation will be important to the development of pharmaceutical inhibitors that specifically inhibit the activation of NF-kappaB. Such inhibitors would be predicted to have potent anti-inflammatory and/or anti-carcinogenic effects.
Insights
Nuclear factor kappa B (NF-kappaB) regulates key cellular processes. Understanding its complex signaling network is crucial for developing targeted therapies for inflammation and cancer.
Area of Science:
- Molecular Biology
- Immunology
- Cell Biology
Background:
- Nuclear factor kappa B (NF-kappaB) is a crucial transcription factor.
- It controls genes involved in immune response, cell development, apoptosis, cell cycle, inflammation, and oncogenesis.
- Upstream signaling pathways activating NF-kappaB are key research areas.
Purpose of the Study:
- To elucidate the upstream signaling molecules involved in NF-kappaB activation.
- To identify potential pharmaceutical targets for inhibiting NF-kappaB.
- To understand the network, rather than linear, nature of NF-kappaB signaling.
Main Methods:
- Review of existing literature on NF-kappaB signaling pathways.
- Analysis of molecular interactions within the NF-kappaB pathway.
- Identification of key signaling molecules and their roles.
Main Results:
- NF-kappaB activation involves a complex network of signaling molecules.
- Many signaling molecules in the pathway can be targeted for pharmaceutical intervention.
- The precise interactions between these molecules are still under investigation.
Conclusions:
- Detailed understanding of NF-kappaB upstream signaling is vital for drug development.
- Targeted inhibition of NF-kappaB activation holds promise for anti-inflammatory and anti-cancer therapies.
- Elucidating the signaling network will enable the design of specific pharmaceutical inhibitors.
More Related Videos
10:57NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells
Published on: January 12, 2020
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
MAPK Signaling Cascades
Amplifying Signals via Enzymatic Cascade
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway
Enzyme-linked Receptors